Whether, with reference to her reply to question 142 on 23 March 2022, her department will implement a mechanism that would make it possible to drastically shorten the time frame required for newly developed and tested vaccines to be registered in emergency situations in order to allow for mass production and use in a short period of time; if not, what is the position in this regard; if so, what are the relevant details;
2) whether, due to the exceptional circumstance of high shortages of vaccines, she ever considered to fast-track the registration of new vaccine product applications by the private sector in terms of the Fertilisers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, Act 36 of 1947; if not, why not; if so, what are the relevant details?